130 related articles for article (PubMed ID: 38461962)
1. Prednisone and ibuprofen conjugate Janus dendrimers and their anticancer activity.
Barajas-Mendoza I; Castillo-Rodríguez IO; Hernández-Rioja I; Ramirez-Apan T; Martínez-García M
Steroids; 2024 May; 205():109395. PubMed ID: 38461962
[TBL] [Abstract][Full Text] [Related]
2. Janus Dendrimers as Nanocarriers of Ibuprofen, Chlorambucil and their Anticancer Activity.
Pedro-Hernández LD; Barajas-Mendoza I; Castillo-Rodríguez IO; Klimova E; Ramírez-Ápan T; Martínez-García M
Pharm Nanotechnol; 2024; 12(3):276-287. PubMed ID: 37592778
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
4. Strain-promoted alkyne azide cycloaddition for the functionalization of poly(amide)-based dendrons and dendrimers.
Ornelas C; Broichhagen J; Weck M
J Am Chem Soc; 2010 Mar; 132(11):3923-31. PubMed ID: 20184364
[TBL] [Abstract][Full Text] [Related]
5. Janus-type dendrimer-like poly(ethylene oxide)s.
Feng X; Taton D; Ibarboure E; Chaikof EL; Gnanou Y
J Am Chem Soc; 2008 Sep; 130(35):11662-76. PubMed ID: 18681431
[TBL] [Abstract][Full Text] [Related]
6. Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers.
Kurtoglu YE; Mishra MK; Kannan S; Kannan RM
Int J Pharm; 2010 Jan; 384(1-2):189-94. PubMed ID: 19825406
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the Anticancer Activity of Chlorambucil and Ibuprofen via Calix[4]arene Conjugates.
Pedro-Hernández LD; Organista-Mateos U; Allende-Alarcón LI; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M
Med Chem; 2020; 16(7):984-990. PubMed ID: 31448714
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Fluorescent, Dumbbell-Shaped Polyurethane Homo- and Heterodendrimers and Their Photophysical Properties.
Poudel DP; Taylor RT
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675178
[TBL] [Abstract][Full Text] [Related]
9. Anticancer Activity of Water-Soluble Olsalazine-PAMAM-Dendrimer-Salicylic Acid-Conjugates.
Cortez-Maya S; Pedro-Hernández LD; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412571
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Polyglycerol, Porphyrin-Cored Dendrimers Using Click Chemistry.
Elmer SL; Man S; Zimmerman SC
European J Org Chem; 2008 Aug; 2008(22):. PubMed ID: 24273441
[TBL] [Abstract][Full Text] [Related]
11. Self-interrupted synthesis of sterically hindered aliphatic polyamide dendrimers.
Jishkariani D; MacDermaid CM; Timsina YN; Grama S; Gillani SS; Divar M; Yadavalli SS; Moussodia RO; Leowanawat P; Berrios Camacho AM; Walter R; Goulian M; Klein ML; Percec V
Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2275-E2284. PubMed ID: 28270599
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Characterization, and Nanomedical Applications of Conjugates between Resorcinarene-Dendrimers and Ibuprofen.
Pedro-Hernández LD; Martínez-Klimova E; Cortez-Maya S; Mendoza-Cardozo S; Ramírez-Ápan T; Martínez-García M
Nanomaterials (Basel); 2017 Jun; 7(7):. PubMed ID: 28665319
[TBL] [Abstract][Full Text] [Related]
13. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Activity of Resorcinarene-PAMAM-Dendrimer Conjugates of Flutamide.
Pedro-Hernández LD; Martínez-Klimova E; Martínez-Klimov ME; Cortez-Maya S; Vargas-Medina AC; Ramírez-Ápan T; Hernández-Ortega S; Martínez-García M
Anticancer Agents Med Chem; 2018; 18(7):993-1000. PubMed ID: 29256355
[TBL] [Abstract][Full Text] [Related]
17. Design considerations for PAMAM dendrimer therapeutics.
Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
[TBL] [Abstract][Full Text] [Related]
18. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
Uram Ł; Filipowicz A; Misiorek M; Pieńkowska N; Markowicz J; Wałajtys-Rode E; Wołowiec S
Eur J Pharm Sci; 2018 Nov; 124():1-9. PubMed ID: 30118847
[TBL] [Abstract][Full Text] [Related]
19.
Nazlı H; Gedik G
Pharm Dev Technol; 2021 Sep; 26(7):750-764. PubMed ID: 34154500
[TBL] [Abstract][Full Text] [Related]
20. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.
Kolhe P; Misra E; Kannan RM; Kannan S; Lieh-Lai M
Int J Pharm; 2003 Jun; 259(1-2):143-60. PubMed ID: 12787643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
